Profile picture of The Washington Post
AstraZeneca will cap inhaler costs at $35 per month: The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device ...
washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/
AstraZeneca will cap inhaler costs at $35 per month
Quick Glance: AstraZeneca caps out-of-pocket costs for inhalers
  • AstraZeneca announced it will cap out-of-pocket costs for inhaled respiratory products in the US at $35 per month, following a similar move by rival Boehringer Ingelheim.

  • This decision comes amidst increasing political scrutiny of high drug prices in the US, particularly for inhalers used to treat asthma and chronic obstructive pulmonary disease.

  • The out-of-pocket cost cap will be effective from June 1 for AstraZeneca's entire respiratory product portfolio, including popular inhalers like Airsupra, Bevespi Aerosphere, and Breztri Aerosphere.

  • AstraZeneca CEO Pascal Soriot emphasized the need for comprehensive healthcare reform to ensure patients can afford essential medications.
Profile picture of Santos Futebol Clube
TODAY THERE ARE VILLAGE MERMAIDS! 🧜‍♀️⚪️⚫️
Profile picture of CityAM
Covid-19 anniversary: How have GSK and Astrazeneca fared since?: GSK and Astrazeneca, both played a role in the battle against Covid-19, but how have they fared ...
cityam.com/covid-19-anniversary-how-have-gsk-and-astrazeneca-fared-since/
Covid-19 anniversary: How have GSK and Astrazeneca fared since?
Profile picture of Bloomberg
UK Risks Critical Medicine Shortage as EU Lures Drugmakers, Sandoz Says: Britain risks running out of critical medicines because it’s failing to stay competitive ...
bloomberg.com/news/articles/2024-03-22/uk-risks-critical-medicine-shortage-as-eu-lures-drugmakers
UK Risks Critical Medicine Shortage as EU Lures Drugmakers, Sandoz Says
Profile picture of Santos Futebol Clube
TODAY THERE ARE VILLAGE MERMAIDS IN THE FIELD! 🧜‍♀️⚪⚫
Profile picture of PTAheute
Urinary tract infection & gonorrhea: new antibiotic tested: There may be a new oral option in the future for treating uncomplicated urinary tract infections and ...
ptaheute.de/aktuelles/2024/03/11/harnwegsinfekt-amp-gonorrhoe-neues-antibiotikum-getestet
Urinary tract infection & gonorrhea: new antibiotic tested
Profile picture of news.abs-cbn.com
Myths and misconceptions about shingles: Myths and misconceptions about shingles
news.abs-cbn.com/lifestyle/2024/3/8/myths-and-misconceptions-about-shingles-1611
Myths and misconceptions about shingles
Profile picture of South Wales Argus
Care & Repair Cymru given funding after winning GSK award: Welsh charity, Care & Repair Cymru (CRC), has won an award for its work helping vulnerable older ...
southwalesargus.co.uk/news/24167895.care-repair-cymru-given-funding-winning-gsk-award/
Care & Repair Cymru given funding after winning GSK award
Profile picture of Bloomberg
New Gonorrhea Pill Is as Good as It Gets Amid Drug Resistant Strains, Says GSK: A new antibiotic pill for gonorrhea was as good as current treatments in a late ...
bloomberg.com/news/articles/2024-02-26/new-gonorrhea-pill-is-as-good-as-it-gets-amid-drug-resistant-strains-says-gsk
New Gonorrhea Pill Is as Good as It Gets Amid Drug Resistant Strains ...
Profile picture of Reuters
GSK settles another lawsuit on heartburn drug Zantac in California: GSK agreed to confidentially settle another lawsuit in California that had alleged its ...
reuters.com/legal/gsk-confidentially-settles-another-california-zantac-lawsuit-2024-02-29/
GSK settles another lawsuit on heartburn drug Zantac in California
Profile picture of CNBC
Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday ... Show more
Profile picture of Bloomberg
GSK Says HIV Shot Is Better than Daily Pills for Some Patients: GSK Plc’s long-acting HIV drug worked better than daily pills for some patients ...
bloomberg.com/news/articles/2024-02-21/gsk-says-hiv-shot-is-better-than-daily-pills-for-some-patients
GSK Says HIV Shot Is Better than Daily Pills for Some Patients
Profile picture of CNBC
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
cnbc.com/2024/02/26/granolas-stocks-power-europe-to-record-highs-drawing-magnificent-7-comparisons.html
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent ...
Profile picture of Reuters
GSK completes acquisition of Aiolos Bio for up to $1.4 bln: GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage ...
reuters.com/business/healthcare-pharmaceuticals/gsk-completes-acquisition-aiolos-bio-up-14-bln-2024-02-15/
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
Profile picture of Al Jazeera
Could new vaccines end malaria in Africa?: A decades-long pursuit to disarm mosquitoes has produced new vaccines. But will they be enough?
aljazeera.com/news/2024/2/12/could-new-vaccines-end-malaria-in-africa
Could new vaccines end malaria in Africa?
Profile picture of The Irish Times
Compensation scheme for medical trial victims at mother and baby homes to open, but GSK won’t contribute
irishtimes.com/health/2024/01/28/compensation-scheme-for-medical-trial-victims-at-mother-and-baby-homes-to-open-but-gsk-wont-contribute/
Compensation scheme for medical trial victims at mother and baby homes to ...
Profile picture of NPR
The malaria vaccine that just rolled out has a surprise benefit for kids: A new malaria vaccine came to Cameroon this week and will be introduced in 20 ...
npr.org/sections/goatsandsoda/2024/01/24/1226387171/the-malaria-vaccine-that-just-rolled-out-has-a-surprise-benefit-for-kids
The malaria vaccine that just rolled out has a surprise benefit for kids
Quick Glance: Cameroon's Landmark Initiative: Malaria Vaccination for Kids
  • Cameroon is launching the world's first malaria vaccination program for children, aiming to vaccinate approximately 250,000 kids this year and next.

  • The campaign's commencement is deemed a pivotal moment in the long-standing battle against the mosquito-borne disease on the continent.

  • Gavi is collaborating with 20 other African nations to assist in vaccine procurement, with hopes of immunizing over 6 million children in these countries by 2025.

  • Neither of the malaria vaccines halts transmission, thus emphasizing the continued significance of tools such as bed nets and insecticidal spraying.
Profile picture of Reuters
GSK settles another Zantac lawsuit in California: GSK (GSK.L) said on Thursday it had agreed to settle another lawsuit in California that alleged its ...
reuters.com/business/healthcare-pharmaceuticals/gsk-confidentially-settles-another-zantac-lawsuit-california-2024-02-01/
GSK settles another Zantac lawsuit in California
Profile picture of CNN.com
Doctors and parents are scrambling after asthma inhaler switch takes popular medication off the market
cnn.com/2024/02/13/health/asthma-medication-flovent/
Doctors and parents are scrambling after asthma inhaler switch takes ...
Profile picture of Ahram Online
GlaxoSmithKline Egypt concluded 2023 with significant sales leap, exceeding two billion pounds, a 23% increase over the previous year ...
english.ahram.org.eg/NewsContent/3/14/518848/Business/Markets--Companies/GlaxoSmithKline-Egypt-concluded--with-significant-.aspx
GlaxoSmithKline Egypt concluded 2023 with significant sales leap ...
Profile picture of The Herald (Glasgow)
Amma Birth Companions scoops GSK IMPACT Award and £40,000 funding: A charity which helps vulnerable woman, refugees and asylum seekers on their journey to giving ...
heraldscotland.com/news/24160397.amma-birth-companions-scoops-gsk-impact-award-40-000-funding/
Amma Birth Companions scoops GSK IMPACT Award and £40,000 funding
Profile picture of CNN.com
23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
cnn.com/2024/02/02/investing/23andme-stock-anne-wojcicki/
23andMe is low on cash and its stock is worth pennies. The CEO wants ...
Profile picture of The Boston Globe
Parents scramble as common children's asthma med disappears: Senator Elizabeth Warren on Friday accused the drug's manufacturer, GlaxoSmithKline ...
bostonglobe.com/2024/03/03/metro/asthma-flovent-glaxo-smith-kline-children-warren/
Parents scramble as common children's asthma med disappears
Profile picture of DER AKTIONÄR
The impressive rally of the S&P 500 is largely driven by seven US technology giants such as Apple and Amazon. But a similar phenomenon can also be found in ... Show more
Profile picture of Deutsches Ärzteblatt
RSV vaccination: US authorities report possible small increase in Guillain-Barré syndromes
aerzteblatt.de/nachrichten/149715/RSV-Impfung-US-Behoerden-melden-moeglichen-geringen-Anstieg-von-Guillain-Barre-Syndromen
RSV vaccination: US authorities report possible small increase in ...
Profile picture of Reuters
GSK beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and ... Show more
Profile picture of Bloomberg
Sanofi (SAN FP): Deal Could Boost Jumbo LBO Comeback: The Sanofi consumer health-care business would be a great deal for private equity — so long as industrial ...
bloomberg.com/opinion/articles/2024-02-26/sanofi-san-fp-deal-could-boost-jumbo-lbo-comeback
Sanofi (SAN FP): Deal Could Boost Jumbo LBO Comeback
Profile picture of Agence France-Presse
Cameroon has launched the first malaria vaccination programme to be offered nationwide and as a matter of routine, in a step the WHO has described as ... Show more
Profile picture of Reuters
GSK sees strong growth as respiratory, cancer portfolio to pay off: GSK (GSK.L) beat market estimates for fourth-quarter results on Wednesday ...
reuters.com/business/healthcare-pharmaceuticals/drugmaker-gsks-fourth-quarter-results-beat-market-estimate-2024-01-31/
GSK sees strong growth as respiratory, cancer portfolio to pay off
Profile picture of The Hill (newspaper)
A dispute over a common asthma drug leaves patients caught in the middle: The most common asthma inhaler for children was discontinued at the start of this year ...
thehill.com/policy/healthcare/4472283-a-dispute-over-a-common-asthma-drug-leaves-patients-caught-in-the-middle/
A dispute over a common asthma drug leaves patients caught in the middle
Profile picture of Financialexpress
Sensodyne launches alcohol-free mouthwash for sensitive teeth: Sensodyne Complete Protection+ Mouthwash is formulated to complement daily brushing ...
financialexpress.com/business/brandwagon-sensodyne-launches-alcohol-free-mouthwash-for-sensitive-teeth-3395304/
Sensodyne launches alcohol-free mouthwash for sensitive teeth
Profile picture of Reuters
GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal: GSK (GSK.L) on Tuesday said it would acquire asthma drug maker Aiolos Bio in a deal worth up to ...
reuters.com/markets/deals/gsk-acquire-aiolos-bio-14-bln-deal-2024-01-09/
GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal
Quick Glance: VW utilizing ChatGPT for driver conversations by mid-year
  • Volkswagen integrating ChatGPT to enable driver conversations by mid-year.

  • First vehicles with ChatGPT available in North America and Europe from early second quarter.

  • AI system capable of recognizing and responding to various demands, such as temperature adjustments and displaying nearby restaurants.
Profile picture of nwemail.co.uk
Newsquest Cumbria thank sponsors ahead of Pride of Cumbria Awards 2024: NEWSQUEST Cumbria has thanked sponsors ahead of the 2024 Pride of Cumbria awards which ...
nwemail.co.uk/news/24112619.newsquest-cumbria-thank-sponsors-ahead-pride-cumbria-awards-2024/
Newsquest Cumbria thank sponsors ahead of Pride of Cumbria Awards 2024
Profile picture of nwemail.co.uk
Newsquest's Pride of Cumbria Awards launched for 2024: CUMBRIA is a county renowned for its community spirit and pride.
nwemail.co.uk/news/24092807.newsquests-pride-cumbria-awards-launched-2024/
Newsquest's Pride of Cumbria Awards launched for 2024
Profile picture of The Rio Times
Multinationals Exit Kenya: German firm Bayer is cutting back in Kenya, handing off major tasks. This follows UK's GlaxoSmithKline and foreshadows
riotimesonline.com/multinationals-exit-kenya/
Multinationals Exit Kenya
Profile picture of ABC
RSV is about to be tackled with a new vaccine in Australia — here's what we know so far
abc.net.au/news/2024-01-19/rsv-respiratory-syncytial-virus-vaccine-rollout/103364786
RSV is about to be tackled with a new vaccine in Australia — here's what ...
Profile picture of Handelsblatt
Pharmaceutical company: GSK buys asthma drug startup: The British group is expanding its business with respiratory diseases. GSK will pay up to $1 ...
handelsblatt.com/unternehmen/industrie/pharmakonzern-gsk-kauft-startup-fuer-asthma-mittel/100005369.html
Pharmaceutical company: GSK buys asthma drug startup
Profile picture of Investor's Business Daily
Teva, GSK Report Bullish Earnings. Here's Where Novartis Fell Short.: Teva stock neared a profit-taking zone Wednesday, while GSK stock bounded briefly out ...
investors.com/news/technology/teva-stock-teva-earnings-q4-2023/
Teva, GSK Report Bullish Earnings. Here's Where Novartis Fell Short.
Profile picture of Westmorland Gazette
Ulverston hospice renovated after me give up day of work: Employees from GSK Ulverston gave up their time to redecorate the office space and corridors at St ...
thewestmorlandgazette.co.uk/news/24071668.ulverston-hospice-renovated-give-day-work/
Ulverston hospice renovated after me give up day of work
Profile picture of The Hindu
Can malaria vaccine rollout be scaled up? | Explained: As Cameroon becomes the first country in the world to launch the RTS, S malaria vaccine for children into ...
thehindu.com/sci-tech/health/can-malaria-vaccine-rollout-be-scaled-up-explained/article67784053.ece
Can malaria vaccine rollout be scaled up? | Explained
Profile picture of The Wall Street Journal
WSJ News Exclusive | Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
wsj.com/health/pharma/drugmakers-raise-prices-of-ozempic-mounjaro-and-hundreds-of-other-drugs-bdac7051
WSJ News Exclusive | Drugmakers Raise Prices of Ozempic, Mounjaro and ...
Profile picture of instyle.de
According to STIKO: New vaccination recommendation against meningococcal B: The Standing Vaccination Commission now recommends vaccinations against meningococcal ...
instyle.de/mini-me/laut-stiko-neue-impfempfehlung-gegen-meningokokken-b
According to STIKO: New vaccination recommendation against meningococcal B
Profile picture of Financialexpress
Dr Reddy’s Laboratories eyes mega brand in UK: Nicotinell, which is sold in patch, gum and lozenge form, is said to be the second-largest nicotine replacement ...
financialexpress.com/healthcare/news-healthcare/dr-reddys-laboratories-eyes-mega-brand-in-uk/3366461/
Dr Reddy’s Laboratories eyes mega brand in UK
Profile picture of Ahram Online
Dr. Hesham Ahmed Abdullah, Senior Vice President, Global Head Oncology, Research and Development (R&D), GSK, explains the company’s commitment to improving ...
english.ahram.org.eg/News/516093.aspx
Dr. Hesham Ahmed Abdullah, Senior Vice President, Global Head Oncology ...
Profile picture of The Washington Post
How to prevent shingles and what to do if you get it: Shingles can be painful, itchy and have long-term side effects. Here’s what to know about preventing and ...
washingtonpost.com/wellness/2024/01/15/shingles-shingrix-vaccine-chickenpox/
How to prevent shingles and what to do if you get it
Profile picture of The Punch
Delisting: SEC, court okay GSK share buyback: This was revealed in a notice filed with the Nigerian Exchange Limited on Thursday.
punchng.com/delisting-sec-court-okay-gsk-share-buyback/
Delisting: SEC, court okay GSK share buyback
Profile picture of CNN.com
Bernie Sanders, Senate Democrats open investigation into price of asthma inhalers
cnn.com/2024/01/08/health/senate-democrats-investigate-price-of-asthma-inhalers/
Bernie Sanders, Senate Democrats open investigation into price of asthma ...